Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 24 for Ibrutinib
  1. Ibrutinib 
    Ibrutinib is used to treat adults with chronic lymphocytic leukemia (CLL; a type of cancer that begins ... cancer that begins mostly in the lymph nodes). Ibrutinib is also used to treat adults with Waldenstrom's ...
    https://medlineplus.gov/druginfo/meds/a614007.html - Drugs and Supplements
  2. Advances in Leukemia Research From the National Institutes of Health (National Cancer Institute)  
    Find out what's new in current leukemia research including progress on targeted therapies and immunotherapies, and NCI programs and clinical trials. ... Acute ...
    https://www.cancer.gov/types/leukemia/research - External Health Links
  3. PLCG2 gene 
    ... Several PLCG2 gene mutations have been associated with ibrutinib resistance, which is a condition in which the drug ibrutinib becomes ineffective in people with these mutations. Ibrutinib ...
    https://medlineplus.gov/genetics/gene/plcg2 - Genetics
  4. Advances in Lymphoma Research From the National Institutes of Health (National Cancer Institute)  
    Lymphoma/Statistics and Research ... Lymphoma ... Hodgkin Lymphoma/Statistics and Research ... Hodgkin Lymphoma ... National Cancer Institute ... From the National Institutes ...
    https://www.cancer.gov/types/lymphoma/research - External Health Links
  5. Staging Primary CNS Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, targeted therapy, and corticosteroids. Learn more about ...
    https://www.cancer.gov/.../primary-cns-lymphoma-treatment-pdq#_18 - External Health Links
  6. Treatment Option Overview (Primary CNS Lymphoma) From the National Institutes of Health (National Cancer Institute)  
    Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, targeted therapy, and corticosteroids. Learn more about ...
    https://www.cancer.gov/.../primary-cns-lymphoma-treatment-pdq#_25 - External Health Links
  7. General Information about Primary CNS Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Lymphoma/Specifics ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Primary central nervous system (CNS) lymphoma treatment options ...
    https://www.cancer.gov/.../primary-cns-lymphoma-treatment-pdq#_1 - External Health Links
  8. CXCR4 gene 
    ... activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of ... CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed ...
    https://medlineplus.gov/genetics/gene/cxcr4 - Genetics
  9. Treatment Option Overview (Adult Non-Hodgkin Lymphoma) From the National Institutes of Health (National Cancer Institute)  
    Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_190 - External Health Links
  10. Stages of Adult Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
    https://www.cancer.gov/.../patient/adult-nhl-treatment-pdq#_158 - External Health Links
previous · 1 · 2 · 3 · next